Related Experiment Videos
Clozapine: an atypical neuroleptic
J Bruhwyler1, E Chleide, M Mercier
1Department of Psychology, Facultés Universitaires Notre-Dame de la Paix, Namur, Belgium.
Neuroscience and Biobehavioral Reviews
|January 1, 1990
Summary
Clozapine, an atypical neuroleptic, differs significantly from classical antipsychotics. This review compares clozapine
Area of Science:
- Pharmacology
- Neuroscience
- Toxicology
Background:
- Clozapine, synthesized in 1960, is classified as an atypical neuroleptic.
- Classical neuroleptics are defined by antipsychotic and extrapyramidal effects in humans, and specific animal model behaviors.
- Clozapine exhibits distinct properties that challenge traditional neuroleptic detection methods.
Purpose of the Study:
- To compare clozapine with classical neuroleptics.
- To evaluate clozapine's unique pharmacological and clinical profile.
Main Methods:
- Comparative analysis of toxicological data.
- Neuropharmacological assessments.
- Psychopharmacological evaluations.
- Clinical observations.
Main Results:
- Clozapine deviates from classical neuroleptic profiles in key toxicological and neuropharmacological tests.
- Traditional tests for neuroleptic potential may not fully capture clozapine's effects.
- Clinical data highlight clozapine's distinct therapeutic and side-effect profile.
Conclusions:
- Clozapine represents a departure from classical neuroleptic pharmacology.
- The distinct characteristics of clozapine necessitate a re-evaluation of neuroleptic classification and testing paradigms.
- Understanding these differences is crucial for optimizing treatment with atypical antipsychotics.